Zydus Lifesciences Ltd - Zydus Lifesciences Limited - Press Release
(04 Sep 2025)

Back
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 04, 2025, titled 'Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules (generic version of ZEPOSIA®) for the U.S. market'.

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew